VanEck ETF Trust VanEck ... Aktie - GENZ

VanEck ETF Trust VanEck Digital Native Economy ETF (GENZ) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

34,4474

( -3,05% )

Gebot

16,68

Fragen

52,30

Volumen

1.717

34,41 Tagesbereich 35,70

34,23 52-Wochen-Bereich 76,25

Handelsende

35,53

Handelsbeginn

35,70

Letzte Trade

34.4474

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

1.600

Finanzvolumen

US$ 59.383

VWAP

34,5853

VanEck Converts Gaming ETF into GENZ ETF Targeting Digital Native Economy

As GenZ and millennials reshape the economy through digital-first behaviors, VanEck is relaunching its Gaming ETF (BJK) as the VanEck Digital...

Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation

Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation -- Company Announces Four-Day Subsequent Offer Period for Remaining...

Standard & Poor's Announces Change to U.S. Index

Standard & Poor's Announces Change to U.S. Index PR Newswire NEW YORK, March 29, 2011 NEW YORK, March 29, 2011 /PRNewswire/ -- BlackRock Inc...

Genzyme Board Unanimously Recommends that Shareholders Accept sanofi-aventis Revised Offer and Tender Shares

Genzyme Corporation (NASDAQ: GENZ) announced today that its Board of Directors unanimously recommends that Genzyme shareholders...

Genzyme Completes Sale of Pharmaceuticals Business to International Chemical Investors Group

Genzyme Corporation (Nasdaq: GENZ) today announced that it has completed the sale of its pharmaceutical intermediates business...

Genzyme Recognizes International Rare Disease Day by Launching New Patient Advocacy Grant Program

Genzyme Corporation (NASDAQ: GENZ) today recognized International Rare Disease Day with the launch of a new program, the...

Three-Year Data from Phase 2 Trial of Genzyme Gaucher Disease Oral Compound Suggest Sustained or Further Improvement Across A...

Genzyme Corporation (NASDAQ: GENZ) today announced three-year follow-up data from patients enrolled in the phase 2 clinical...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-0.9426	-2.66346425544	35.39	36.75	34.435	2984	35.20388177	SP
4	-1.1226	-3.15603036267	35.57	36.75	34.435	2691	35.32469087	SP
12	-41.8026	-54.8230819672	76.25	76.25	34.23	1600	35.94121703	SP
26	-41.8026	-54.8230819672	76.25	76.25	34.23	748	35.94121703	SP
52	-41.8026	-54.8230819672	76.25	76.25	34.23	370	35.94121703	SP
156	-41.8026	-54.8230819672	76.25	76.25	34.23	124	35.94121703	SP
260	-41.8026	-54.8230819672	76.25	76.25	34.23	74	35.94121703	SP

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
WIG1Wige Media AG	0,0085 € (142,86%)	515k
7YGSyntheia Corp	0,0228 € (78,13%)	1,06M
52N0Solidion Technology Inc	31,00 € (58,97%)	179,38k
SRISun Art Retail Group Limited	0,1855 € (41,50%)	113
000Bitzero Holdings Inc	7,20 € (39,81%)	34,02k
5MCCypherpunk Technologies Inc	0,442 € (-48,00%)	1,04M
PU11Social Chain AG	0,0055 € (-45,00%)	10
N7RNoram Lithium Corp	0,076 € (-31,53%)	194,22k
FCTWFintechWerx International Software Services Inc	0,3535 € (-27,71%)	25,75k
BVU3St James Gold Corp	0,0425 € (-26,72%)	6k
D7GNel ASA	0,259 € (-12,79%)	11,04M
PF8European Lithium Limited	0,2465 € (-8,70%)	3,96M
PLIXPrairie Lithium Ltd	0,0043 € (0,00%)	3,27M
DRHDroneShield Limited	1,7815 € (-3,18%)	2,72M
PLUNPlug Power Inc	2,797 € (-9,90%)	1,89M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

VanEck ETF Trust VanEck Digital Native Economy ETF (GENZ)

VanEck ETF Trust VanEck Digital Native Economy ETF (GENZ) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

GENZ Neueste Nachrichten

VanEck Converts Gaming ETF into GENZ ETF Targeting Digital Native Economy

Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation

Standard & Poor's Announces Change to U.S. Index

Genzyme Board Unanimously Recommends that Shareholders Accept sanofi-aventis Revised Offer and Tender Shares

Genzyme Completes Sale of Pharmaceuticals Business to International Chemical Investors Group

Genzyme Recognizes International Rare Disease Day by Launching New Patient Advocacy Grant Program

Three-Year Data from Phase 2 Trial of Genzyme Gaucher Disease Oral Compound Suggest Sustained or Further Improvement Across A...

Genzyme Reports Financial Results for Fourth Quarter of 2010 and Full Year

Video Available: Sanofi-aventis to Acquire Genzyme for $74.00 in Cash per Share Plus Contingent Value Right

Sanofi-aventis to Acquire Genzyme for $74.00 in Cash Per Share Plus Contingent Value Right

VanEck Converts Gaming ETF into GENZ ETF Targeting Digital Native Economy

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

VanEck ETF Trust VanEck Digital Native Economy ETF (GENZ)

VanEck ETF Trust VanEck Digital Native Economy ETF (GENZ) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

GENZ Neueste Nachrichten

VanEck Converts Gaming ETF into GENZ ETF Targeting Digital Native Economy

Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation

Standard & Poor's Announces Change to U.S. Index

Genzyme Board Unanimously Recommends that Shareholders Accept sanofi-aventis Revised Offer and Tender Shares

Genzyme Completes Sale of Pharmaceuticals Business to International Chemical Investors Group

Genzyme Recognizes International Rare Disease Day by Launching New Patient Advocacy Grant Program

Three-Year Data from Phase 2 Trial of Genzyme Gaucher Disease Oral Compound Suggest Sustained or Further Improvement Across A...

Genzyme Reports Financial Results for Fourth Quarter of 2010 and Full Year

Video Available: Sanofi-aventis to Acquire Genzyme for $74.00 in Cash per Share Plus Contingent Value Right

Sanofi-aventis to Acquire Genzyme for $74.00 in Cash Per Share Plus Contingent Value Right

VanEck Converts Gaming ETF into GENZ ETF Targeting Digital Native Economy

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Registrieren Sie sich GRATIS und erhalten Sie:

Werbung entfernen